Certara, Inc.
General ticker "CERT" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.9B (TTM average)
Certara, Inc. does not follow the US Stock Market performance with the rate: -11.8%.
Estimated limits based on current volatility of 3.7%: low 6.92$, high 7.45$
Factors to consider:
- Total employees count: 1546 as of 2024
- North and South America accounted for 74.8% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Regulatory and compliance, Pricing pressures, Customer growth risks, Acquisition/divestiture risks, Litigation risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.61$, 11.50$]
- 2026-12-31 to 2027-12-31 estimated range: [6.61$, 11.45$]
Financial Metrics affecting the CERT estimates:
- Positive: with PPE of 20.3 at the end of fiscal year the price was low
- Positive: -4.75 < Operating profit margin, % of 5.02
- Positive: 6.64 < Operating cash flow per share per price, % of 6.73
- Negative: negative Industry operating cash flow (median)
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
- Negative: Shareholder equity ratio, % of 68.28 > 64.29
- Negative: Inventory ratio change, % of 1.55 > 0.80
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 1.38 <= 3.28
Short-term CERT quotes
Long-term CERT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $354.34MM | $385.15MM | $418.84MM |
| Operating Expenses | $395.11MM | $386.88MM | $397.82MM |
| Operating Income | $-40.77MM | $-1.73MM | $21.02MM |
| Non-Operating Income | $-14.37MM | $-15.45MM | $-13.40MM |
| Interest Expense | $22.92MM | $21.52MM | $19.74MM |
| R&D Expense | $34.17MM | $37.10MM | $41.04MM |
| Income(Loss) | $-55.14MM | $-17.18MM | $7.62MM |
| Taxes | $0.21MM | $-5.13MM | $9.21MM |
| Profit(Loss)* | $-55.36MM | $-12.05MM | $-1.59MM |
| Stockholders Equity | $1,046.84MM | $1,058.66MM | $1,062.80MM |
| Assets | $1,563.14MM | $1,575.10MM | $1,556.58MM |
| Operating Cash Flow | $82.75MM | $80.47MM | $96.33MM |
| Capital expenditure | $1.78MM | $1.62MM | $1.76MM |
| Investing Cash Flow | $-79.55MM | $-112.37MM | $-26.56MM |
| Financing Cash Flow | $-9.45MM | $-21.01MM | $-63.99MM |
| Earnings Per Share** | $-0.35 | $-0.08 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.